Serenitin Plus
Natural health product licensed in Canada
- Licence holder
- Douglas Laboratories Canada
- NPN or DIN-HM
- 80036114
- Status
- Active licence
- Licence date
- 2 October 2012
- Revision date
- Not provided
- Form
- Capsule
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine, Carbonate de calcium, Stéarate de magnésium, cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 day |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps temporarily reduce symptoms of mild mental and physical stress. Vitamin D is a factor in the maintenance of good health, helps in the development and maintenance of bones and teeth, helps in the absorption and use of calcium.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80036114
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.